Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 double-blind study of HYZ2001 capsules for preventive treatment of migraine
CTR20262219Phase 2Active
- Sponsor
- Tiandi Hengyi Pharmaceutical
- Start
- Jun 2026
- Countries
- 1
01
Overview
A Phase 2 trial of HYZ2001 in migraine, sponsored by Tiandi Hengyi Pharmaceutical. Started Jun 2026; status: active.
02
Drugs
HYZ2001
03
Conditions
migraine
Beyond the preview
Go deeper on CTR20262219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262219.